Verily, a Dallas, TX-based provider of a data platform supporting AI-enabled precision health solutions, has raised $300 million in a funding round led by Series X Capital.
The round also saw participation from Alphabet, UCHealth, the University of Colorado Anschutz, and other investors.
The company plans to use the funds to advance the next stage of its precision health AI strategy.
Read More:Health Universe Raises $6M in Seed Funding
With this investment, Verily has changed its legal structure from an LLC to a corporation, now called Verily Health Inc. The company plans to speed up its AI-based precision health platform to help customers organize healthcare data and use it to guide research and care workflows.
Verily has also announced several commercial partnerships, including one with Samsung’s Galaxy Watch to support clinical research through biomarker development on the Pre platform, and a strategic partnership with Salesforce to integrate the Verily Pre Platform with Agentforce Health for enterprise precision health solutions. These efforts build on Verily’s existing collaborations with UCHealth, the University of Colorado Anschutz, and RefinedScience, all of which use the Pre platform for AI-driven research and care improvements.
Verily started at Google X ten years ago as one of Alphabet’s first “Other Bets,” focusing on breakthrough science and health technology innovations.
“Today marks an important step in our mission to make precision health accessible to everyone,” said Stephen Gillett Chairman and CEO of Verily. “Our customers need solutions that combine clinical and scientific rigor with AI to deliver healthcare that is both precise and personal. Series X Capital, Alphabet, UCHealth, the University of Colorado Anschutz, and our investors will be key partners in this transformation.”
“Series X Capital was created with Google’s X, The Moonshot Factory, to scale breakthrough technologies into world-changing companies,” said Gideon Yu, Founder and Managing Partner of Series X Capital. “We are thrilled to lead this milestone round for Verily as they continue to advance commercial momentum in precision health.”
“At Alphabet, we applaud Verily’s dedication to using technology to tackle long-standing healthcare challenges,” said Ruth Porat, President & Chief Investment Officer of Alphabet and Google. “Bringing in new investors, alongside Alphabet’s continued support, allows Verily to scale its AI health platform to improve patient outcomes and reduce healthcare costs.”
“Partnering with Verily to create a shared, AI-ready data framework for healthcare is a generational opportunity for UCHealth and medicine,” said Dr. Richard Zane, UCHealth Chief Medical and Innovation Officer. “This collaboration helps realize the promise of personalized care, benefiting patients and saving lives. We’re excited to get started.”
About Verily
Founded in 2015, by Stephen Gillett, Verily is a technology and data platform company that builds AI-powered precision health solutions to speed research and improve care for individuals and communities. By combining technology, data science, and healthcare, Verily turns health data into actionable insights and models that make healthcare more personal, predictive, and precise.
Read More:Findem to Acquire Glider to Deliver Hire-Ready Candidates
